Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing and therefore is its burden of disease as NALFD is a risk factor for cirrhosis and is associated with other metabolic conditions such as type II diabetes, obesity, dyslipidaemia and atherosclerosis. Linking these cardiometabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Teunis, Charlotte, Nieuwdorp, Max, Hanssen, Nordin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227929/
https://www.ncbi.nlm.nih.gov/pubmed/35736447
http://dx.doi.org/10.3390/metabo12060514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227929/
https://www.ncbi.nlm.nih.gov/pubmed/35736447
http://dx.doi.org/10.3390/metabo12060514

Ejemplares similares